Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × darolutamide × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

Injections 27 toripalimab 17 pembrolizumab 17 tislelizumab 12 Gemcitabine 8 Cisplatin 7 spartalizumab 6 atezolizumab 6 Paclitaxel 6 Oxaliplatin 6 Leucovorin 6 Irinotecan 6 Fluorouracil 6 Carboplatin 6 Nivolumab 5 camrelizumab 4 Pemetrexed 4 Docetaxel 4 Cetuximab 4 Capecitabine 4 Bevacizumab 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 lenvatinib 3 cediranib 3 PM 01183 3 Drug Therapy 3 Cyclophosphamide 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06220864 2026-04-14

SNV1521 in Participants With Advanced Solid Tumors

Synnovation Therapeutics, Inc.

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡